None of the KLS positive transplant recipient mice died from rapidly fatal disease or exhibited clear clinical findings consistent with AML, MDS, or graft-versus-host disease apart from rare dysplastic cells of unclear significance. This evidence concerns the gene RPS6KB2 and myelodysplastic syndrome.